NORMAL SITUATION

PHARMPHY

Export PDF

Financial year 2023 · closed on 31/12/2023

Net result

94,8 k €

+95.8% YoY

Gross margin

134,1 k €

+50.4% YoY

Equity

420,1 k €

+29.1% YoY

Company — Normal situation.

What does PHARMPHY do?

PHARMPHY is a company registered in Belgium.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0864.439.155

Legal form

Private company with limited liability

Contributed capital

6 200,00 €

Latest accounts

31/12/2023

Joint committees (1)

Signals

ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	134,1 k €	+50.4%	89,2 k €	-22.2%	114,6 k €	+14.2%	100,3 k €	+60.8%	62,4 k €	-1.9%	63,6 k €	-7.3%	68,7 k €	-38.1%	110,9 k €	-15.4%	131,1 k €	+53.4%	85,4 k €	-4.8%	89,8 k €	-13.1%	103,3 k €	-7.2%	111,3 k €	+42.5%	78,1 k €	+0.4%	77,8 k €	-14.1%	90,6 k €	+8.4%	83,6 k €	+1.1%	82,7 k €
EBITDA	126,4 k €	+62.1%	78 k €	-29.2%	110,1 k €	+14.3%	96,4 k €	+65.6%	58,2 k €	-0.0%	58,2 k €	-10.4%	65 k €	-38.5%	105,8 k €	-17.8%	128,8 k €	+62.1%	79,4 k €	+0.3%	79,2 k €	-7.4%	85,6 k €	-10.8%	95,9 k €	+39.4%	68,8 k €	-2.4%	70,5 k €	-15.3%	83,3 k €	+5.2%	79,2 k €	-2.8%	81,5 k €
Operating result	126,4 k €	+98.7%	63,6 k €	-35.1%	98 k €	+25.6%	78,1 k €	+99.4%	39,1 k €	+0.8%	38,9 k €	-15.3%	45,9 k €	-47.0%	86,5 k €	-22.2%	111,1 k €	+133%	47,6 k €	+85.6%	25,7 k €	-15.8%	30,5 k €	-26.7%	41,6 k €	+197%	14 k €	+21.3%	11,5 k €	-37.8%	18,6 k €	+15.1%	16,1 k €	-33.6%	24,3 k €
Net result	94,8 k €	+95.8%	48,4 k €	-37.4%	77,3 k €	+40.0%	55,2 k €	+108%	26,6 k €	+3.6%	25,7 k €	-3.4%	26,5 k €	-47.4%	50,4 k €	-22.7%	65,2 k €	+151%	26 k €	+211%	8,4 k €	-29.5%	11,9 k €	-40.1%	19,8 k €	+469%	-5,4 k €	+36.5%	-8,5 k €	-477%	-1,5 k €	-111%	13 k €	+30.5%	9,9 k €
Balance sheet
Equity	420,1 k €	+29.1%	325,3 k €	+17.5%	276,9 k €	+7.2%	258,4 k €	-3.7%	268,3 k €	+11.0%	241,8 k €	+11.9%	216,1 k €	+14.0%	189,6 k €	+36.2%	139,1 k €	+88.2%	73,9 k €	+54.2%	48 k €	+21.1%	39,6 k €	+42.7%	27,7 k €	+248%	8 k €	-40.3%	13,3 k €	-38.8%	21,8 k €	-6.3%	23,2 k €	+127%	10,3 k €
Total assets	428,5 k €	+0.8%	425 k €	-1.8%	432,6 k €	+8.0%	400,4 k €	+16.6%	343,4 k €	-0.8%	346 k €	-4.8%	363,6 k €	-17.9%	442,6 k €	-0.3%	443,7 k €	+18.1%	375,8 k €	-5.7%	398,4 k €	-9.9%	442,3 k €	-6.6%	473,6 k €	+1.2%	468,1 k €	-13.5%	541,4 k €	-4.3%	566 k €	-10.4%	631,8 k €	-2.1%	645,6 k €
Cash	352,4 k €	+140%	146,9 k €	-13.7%	170,2 k €	+31.4%	129,5 k €	+109%	62 k €	+14.4%	54,2 k €	-2.7%	55,7 k €	-39.5%	92,1 k €	-36.0%	143,8 k €	+133%	61,9 k €	-38.3%	100,2 k €	+15.7%	86,6 k €	-0.9%	87,4 k €	+489%	14,8 k €	-60.5%	37,6 k €	+24.0%	30,3 k €	-50.2%	60,8 k €	+131%	26,3 k €
Debts	2,7 k €	-97.3%	99,6 k €	-36.0%	155,7 k €	+9.6%	142,1 k €	+89.2%	75,1 k €	-28.0%	104,3 k €	-29.3%	147,5 k €	-41.7%	253,1 k €	-16.9%	304,6 k €	+0.9%	301,9 k €	-12.4%	344,7 k €	-13.4%	398,1 k €	-9.8%	441,2 k €	-3.1%	455,5 k €	-12.9%	522,9 k €	-3.1%	539,7 k €	-10.7%	604,1 k €	-4.2%	630,5 k €
Other
Workforce	–		–		–		–		–		–		–		–		–		–		0,2 ETP	-88.9%	1,8 ETP	+350%	0,4 ETP	+100%	0,2 ETP	0.0%	0,2 ETP	0.0%	0,2 ETP	+100%	0,1 ETP		–

Governance

Board of directors

Seen on filing of 31/12/2023 · 2 active · 8 ended

Active mandates

Bénédicte Guisset

Director · since 01 janvier 2023

Active

Elise De Coninck

Director · since 01 janvier 2023

Active

Ended mandates

Anne-Sophie Henry

Director · since 25 mars 2004 · until 01 janvier 2023

Ended

Anne-Sophie Henry

Director · since 25 mars 2004

Ended

Anne-Sophie Henry

Manager · since 25 mars 2004

Ended

Sébastien Petithan

Director · since 25 mars 2004 · until 01 janvier 2023

Ended

Annual accounts

Full financial information

	2023	2022	2021	2020	2019	2018
Type of account	Abridged model	Abridged model	Micro model	Micro model	Abridged model	Abridged model
Start of the financial year	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019	01/01/2018
Closing of the financial year	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019	31/12/2018
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	26/02/2024	13/07/2023	01/07/2022	30/06/2021	02/07/2020	08/08/2019
General meeting	29/01/2024	24/06/2023	25/06/2022	26/06/2021	27/06/2020	29/06/2019
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

18 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2023	29/01/2024	26/02/2024	French	PDF
Abridged model	31/12/2022	24/06/2023	13/07/2023	French	PDF
Micro model	31/12/2021	25/06/2022	01/07/2022	French	PDF
Micro model	31/12/2020	26/06/2021	30/06/2021	French	PDF
Abridged model	31/12/2019	27/06/2020	02/07/2020	French	PDF
Abridged model	31/12/2018	29/06/2019	08/08/2019	French	PDF
Abridged model	31/12/2017	30/06/2018	25/07/2018	French	PDF
Abridged model	31/12/2016	24/06/2017	11/07/2017	French	PDF
Abridged model	31/12/2015	25/06/2016	05/07/2016	French	PDF
Abridged model	31/12/2014	27/06/2015	30/06/2015	French	PDF
Abridged model	31/12/2013	28/06/2014	01/07/2014	French	PDF
Abridged model	31/12/2012	29/06/2013	25/07/2013	French	PDF
Abridged model	31/12/2011	30/06/2012	02/07/2012	French	PDF
Abridged model	31/12/2010	25/06/2011	27/06/2011	French	PDF
Abridged model	31/12/2009	26/06/2010	29/06/2010	French	PDF
Abridged model	31/12/2008	27/06/2009	30/06/2009	French	PDF
Abridged model	31/12/2007	28/06/2008	14/07/2008	French	PDF
Abridged model	31/12/2006	30/06/2007	05/07/2007	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2023 · 2 active · 8 ended

Active mandates

Bénédicte Guisset

Director · since 01 janvier 2023

Active

Elise De Coninck

Director · since 01 janvier 2023

Active

Ended mandates

Anne-Sophie Henry

Director · since 25 mars 2004 · until 01 janvier 2023

Ended

Anne-Sophie Henry

Director · since 25 mars 2004

Ended

Anne-Sophie Henry

Manager · since 25 mars 2004

Ended

Sébastien Petithan

Director · since 25 mars 2004 · until 01 janvier 2023

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2023
Annual accounts 202394,8 k €↑
2022
Annual accounts 202248,4 k €↓
2021
Annual accounts 202177,3 k €↑
2020
Annual accounts 202055,2 k €↑
2019
Annual accounts 201926,6 k €↑
2018
Annual accounts 201825,7 k €↓
2017
Annual accounts 201726,5 k €↓
2016
Annual accounts 201650,4 k €↓
2015
Annual accounts 201565,2 k €↑
2014
Annual accounts 201426 k €↑
2013
Annual accounts 20138,4 k €↓
2012
Annual accounts 201211,9 k €↓
2011
Annual accounts 201119,8 k €↑
2010
Annual accounts 2010-5,4 k €↑
2009
Annual accounts 2009-8,5 k €↓
2008
Annual accounts 2008-1,5 k €↓
2007
Annual accounts 200713 k €↑
2006
Annual accounts 20069,9 k €

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMPHY

Overview

What does PHARMPHY do?

Trend over 18 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Similar companies

Similar companies

Timeline